QOP
SANA icon

Quinn Opportunity Partners’s Sana Biotechnology SANA Stock Holding History

Quinn Opportunity Partners’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$210K Hold
60,100
– – 0.01% 325
2026
Q1 		$173K Hold
60,100
– – 0.01% 326
2025
Q4 		$245K Sell
60,100
-60,000
-50% -$269K 0.01% 322
2025
Q3 		$426K Hold
120,100
– – 0.03% 247
2025
Q2 		$328K Hold
120,100
– – 0.03% 272
2025
Q1 		$202K Buy
+120,100
New +$336K 0.01% 333

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Quinn Opportunity Partners's SANA Position: Q2 2026 in Review

Quinn Opportunity Partners held its Sana Biotechnology (SANA) position steady in Q2 2026 at 60,100 shares worth $210K. The position accounts for 0.01% of the portfolio, ranked #325.

Quinn Opportunity Partners first reported a position in SANA in Q1 2025 and has held it in 6 quarters since. The position peaked at $426K in Q3 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Quinn Opportunity Partners held 60,100 shares of Sana Biotechnology worth $210K as of Q2 2026.
  • Quinn Opportunity Partners left its Sana Biotechnology share count unchanged in Q2 2026.
  • Sana Biotechnology made up 0.01% of Quinn Opportunity Partners's portfolio in Q2 2026, its #325 holding.
  • Quinn Opportunity Partners first reported a position in Sana Biotechnology in Q1 2025 and has held it in 6 quarters since.
  • Quinn Opportunity Partners's Sana Biotechnology position peaked at $426K in Q3 2025.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Quinn Opportunity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.